Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hiprex in Recurrent Urinary Tract Infections in Women
NCT04709601Phase 4Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methenamine hippurate in urinary tract infection (UTI), sponsored by UT Southwestern Medical Center. Started Jan 2021; status: terminated.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04709601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709601.